Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 3, 2025 • 3:30 AM ET

Date/Time Source News Release
12/19/2024 09:05 AM EST ACCESSWIRE Lexaria's Registered GLP-1 Study #4 Begins Dosing
12/18/2024 09:25 AM EST TheNewsWire Lexaria Forms New Scientific Advisory Board
12/17/2024 09:10 AM EST TheNewsWire Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience
12/09/2024 09:10 AM EST ACCESSWIRE Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5
11/30/2024 11:00 AM EST Newsfile BTV Features these Stocks to Watch: Contango Ore, First Nordic Metals, Champion Iron, Prime Mining, Lexaria Bioscience, Osisko Development, West Red Lake Gold Mines, & Surge Battery Metals
11/26/2024 09:20 AM EST TheNewsWire Revolutionizing Healthcare: Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs
11/25/2024 09:00 AM EST TheNewsWire Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled
11/20/2024 09:05 AM EST ACCESSWIRE ALL Study Groups using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
11/20/2024 09:05 AM EST TheNewsWire ALL Study Groups using DehydraTECH Processing Outperform Rybelsus in Body Weight Control in Lexaria's 12-Week GLP-1, Diabetes Animal Study
11/14/2024 09:10 AM EST TheNewsWire Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study
Page

Additional News

As of January 3, 2025 • 3:30 AM ET

Date/Time Source News Release
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Lexaria Bioscience Corp.
11/26/2024 06:52 PM EST BTV Bulletin Lexaria Bioscience: Advancing GLP-1 Drug Delivery with DehydraTECH(TM) Technology
11/25/2024 07:59 PM EST BTV Bulletin Lexaria Bioscience: Advancing GLP-1 Drug Delivery with Hydrotec Technology
11/24/2024 08:01 AM EST SeekingAlpha Earnings week ahead: CRWD, DELL, ZM, WDAY, HPQ, M, BBY and more
10/15/2024 09:43 AM EDT SeekingAlpha Lexaria Bioscience announces $5M securities offering
10/09/2024 09:45 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins Subject Dosing in Human Pilot Study #3 Evaluating Oral DehydraTECH-Processed Tirzepatide
10/08/2024 10:00 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Update on Growth of GLP-1 Market Space, Notes Potential for Oral Delivery
10/01/2024 08:30 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Strengthen Executive Team in Anticipation of 'Strong Growth' into 2025
09/27/2024 10:00 AM EDT InvestorBrandNetwork InvestorNewsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Begin Human Pilot Study #3 Evaluating DehydraTECH-Processed Tirzepatide
09/20/2024 03:30 PM EDT InvestorBrandNetwork TinyGemsBreaks - Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating 'More Effective, Tolerable' Oral Delivery of GLP-1 Drugs
Page